Skip to main content
Top
Published in: BMC Ophthalmology 1/2017

Open Access 01-12-2017 | Case report

Vitreous hemorrhage and Rhegmatogenous retinal detachment that developed after botulinum toxin injection to the extraocular muscle: case report

Authors: Dong Hyun Lee, Jinu Han, Sueng-Han Han, Sung Chul Lee, Min Kim

Published in: BMC Ophthalmology | Issue 1/2017

Login to get access

Abstract

Background

The authors report a case of a rare complication that occurred after botulinum toxin injection to the extraocular muscle, which was easily overlooked and successfully corrected by surgery.

Case presentation

A 34-year-old female patient visited our clinic for diplopia and ocular motility disorder after removal of an epidermoid tumor of the brain. At her initial visit, her best-corrected visual acuity (BCVA) was 20/20 for both eyes. An alternate cover test showed 45 prism-diopter esotropia and 3 prism-diopter hypertropia in the right eye. Following 6 months of observation, the deviation of the strabismus did not improve, and botulinum toxin was injected into the right medial rectus (RMR). After 6 days, she visited our clinic with decreased visual acuity of her right eye. The BCVA was found to be 20/50 for her right eye. Funduscopic examination presented a retinal tear inferonasal to the optic disc with preretinal hemorrhage. Subretinal fluid nasal to the fovea was seen on optical coherence tomography (OCT). Barrier laser photocoagulation was done around the retinal tear; however, her visual acuity continued to decrease, and vitreous hemorrhage and subretinal fluid at the lesion did not improve. In addition, a newly developed epiretinal membrane was seen on OCT. An alternate cover test presented 30 prism-diopter right esotropia. 19 weeks after RMR botulinum toxin injection, she received pars plana vitrectomy, membranectomy, endolaser barrier photocoagulation, and intravitreal bevacizumab (Avastin®) injection. After 4 months, her visual acuity improved to 20/20, and only 4 prism-diopter of right hypertropia and 3 prism-diopter of exotropia were noted. Vitreous opacity and the epiretinal membrane were completely removed, as confirmed by funduscopic and examination.

Conclusions

Sudden loss of vision after injection of botulinum toxin into the extraocular muscle may suggest a serious complication, and a prompt, thorough ophthalmic examination should be performed. If improvements are not observed, rapid surgical intervention is recommended to prevent additional complications.
Appendix
Available only for authorised users
Literature
2.
go back to reference Sung Y, Nam SM, Lew H. Clinical outcomes of individualized botulinum neurotoxin type a injection techniques in patients with essential blepharospasm. Korean J Ophthalmol. 2015;29(2):115–20.CrossRefPubMedPubMedCentral Sung Y, Nam SM, Lew H. Clinical outcomes of individualized botulinum neurotoxin type a injection techniques in patients with essential blepharospasm. Korean J Ophthalmol. 2015;29(2):115–20.CrossRefPubMedPubMedCentral
3.
go back to reference Chuenkongkaew W. Botulinum toxin treatment for upper lid retraction of dysthyroidism. J Med Assoc Thail. 2003;86(11):1051–4. Chuenkongkaew W. Botulinum toxin treatment for upper lid retraction of dysthyroidism. J Med Assoc Thail. 2003;86(11):1051–4.
4.
5.
go back to reference Cooper L, Lui M, Nduka C. Botulinum toxin treatment for facial palsy: a systematic review. J Plast Reconstr Aesthet Surg. 2017;70(6):833–41.CrossRefPubMed Cooper L, Lui M, Nduka C. Botulinum toxin treatment for facial palsy: a systematic review. J Plast Reconstr Aesthet Surg. 2017;70(6):833–41.CrossRefPubMed
6.
go back to reference Akbari MR, Ameri A, Keshtkar Jaafari AR, Mirmohammadsadeghi A. Botulinum toxin injection for restrictive myopathy of thyroid-associated orbitopathy: success rate and predictive factors. J aapos. 2016;20(2):126–30. e121CrossRefPubMed Akbari MR, Ameri A, Keshtkar Jaafari AR, Mirmohammadsadeghi A. Botulinum toxin injection for restrictive myopathy of thyroid-associated orbitopathy: success rate and predictive factors. J aapos. 2016;20(2):126–30. e121CrossRefPubMed
7.
go back to reference Haugstad M, Moosmayer S, Bragadόttir R. Primary rhegmatogenous retinal detachment - surgical methods and anatomical outcome. Acta Ophthalmol. 2017;95(3):247–51. Haugstad M, Moosmayer S, Bragadόttir R. Primary rhegmatogenous retinal detachment - surgical methods and anatomical outcome. Acta Ophthalmol. 2017;95(3):247–51.
8.
go back to reference Ciprian D. The Pathogeny of proliferative Vitireoretinopathy. Rom J Ophthalmol. 2015;59(2):88–92.PubMed Ciprian D. The Pathogeny of proliferative Vitireoretinopathy. Rom J Ophthalmol. 2015;59(2):88–92.PubMed
9.
go back to reference Danielescu C, Zugun-Eloae F, Zlei M. Concentrations of Vitreal cytokines in Rhegmatogenous retinal detachment. Rev Med Chir Soc Med Nat Iasi. 2016;120(1):124–9.PubMed Danielescu C, Zugun-Eloae F, Zlei M. Concentrations of Vitreal cytokines in Rhegmatogenous retinal detachment. Rev Med Chir Soc Med Nat Iasi. 2016;120(1):124–9.PubMed
10.
go back to reference Yang S, Li H, Li M, Wang F. Mechanisms of epithelial-mesenchymal transition in proliferative vitreoretinopathy. Discov Med. 2015;20(110):207–17.PubMed Yang S, Li H, Li M, Wang F. Mechanisms of epithelial-mesenchymal transition in proliferative vitreoretinopathy. Discov Med. 2015;20(110):207–17.PubMed
11.
13.
go back to reference Liu M, Lee HC, Hertle RW, Ho AC. Retinal detachment from inadvertent intraocular injection of botulinum toxin a. Am J Ophthalmol. 2004;137(1):201–2.CrossRefPubMed Liu M, Lee HC, Hertle RW, Ho AC. Retinal detachment from inadvertent intraocular injection of botulinum toxin a. Am J Ophthalmol. 2004;137(1):201–2.CrossRefPubMed
14.
go back to reference Agrawal S, Singh V, Gupta SK, Kumar BV. Vitreous hemorrhage following inadvertent intra-ocular injection of botulinum toxin. Oman J Ophthalmol. 2015;8(1):79–80.CrossRefPubMedPubMedCentral Agrawal S, Singh V, Gupta SK, Kumar BV. Vitreous hemorrhage following inadvertent intra-ocular injection of botulinum toxin. Oman J Ophthalmol. 2015;8(1):79–80.CrossRefPubMedPubMedCentral
15.
go back to reference Mohan M, Fleck BW. Globe perforation during botulinum toxin injection. Br J Ophthalmol. 1999;83(4):503–4.CrossRefPubMed Mohan M, Fleck BW. Globe perforation during botulinum toxin injection. Br J Ophthalmol. 1999;83(4):503–4.CrossRefPubMed
16.
go back to reference Kutluk S, Akar S, Topcu M, Kural G. Effect of botulinum toxin injections into rabbit eye. Strabismus. 1999;7(4):221–6.CrossRefPubMed Kutluk S, Akar S, Topcu M, Kural G. Effect of botulinum toxin injections into rabbit eye. Strabismus. 1999;7(4):221–6.CrossRefPubMed
17.
go back to reference Gatzioufas Z, Stupp T, Moschos MM, Kopsidas K, Charalambous P, Thanos S. Effect of botulinum toxin a on the intraocular pressure and the retina in an animal model. Cutan Ocul Toxicol. 2013;32(2):107–11.CrossRefPubMed Gatzioufas Z, Stupp T, Moschos MM, Kopsidas K, Charalambous P, Thanos S. Effect of botulinum toxin a on the intraocular pressure and the retina in an animal model. Cutan Ocul Toxicol. 2013;32(2):107–11.CrossRefPubMed
18.
go back to reference Pehere N, Jalali S, Mathai A, Naik M, Ramesh K. Inadvertent intraocular injection of botulinum toxin a. J Pediatr Ophthalmol Strabismus. 2011;48 Online:e1–3.PubMed Pehere N, Jalali S, Mathai A, Naik M, Ramesh K. Inadvertent intraocular injection of botulinum toxin a. J Pediatr Ophthalmol Strabismus. 2011;48 Online:e1–3.PubMed
19.
go back to reference Zheng L, Azar D. Angle-closure glaucoma following periorbital botulinum toxin injection. Clin Exp Ophthalmol. 2014;42(7):690–3.CrossRefPubMed Zheng L, Azar D. Angle-closure glaucoma following periorbital botulinum toxin injection. Clin Exp Ophthalmol. 2014;42(7):690–3.CrossRefPubMed
20.
go back to reference Lennerstrand G, Nordbo OA, Tian S, Eriksson-Derouet B, Ali T. Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta Ophthalmol Scand. 1998;76(1):27.CrossRefPubMed Lennerstrand G, Nordbo OA, Tian S, Eriksson-Derouet B, Ali T. Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta Ophthalmol Scand. 1998;76(1):27.CrossRefPubMed
21.
go back to reference Wan XM, Chu RX, Gong HQ. Minimally invasive botulinum toxin type a injection from the ocular surface to extraocular muscles. Int J Ophthalmol. 2011;4(2):179–81.PubMedPubMedCentral Wan XM, Chu RX, Gong HQ. Minimally invasive botulinum toxin type a injection from the ocular surface to extraocular muscles. Int J Ophthalmol. 2011;4(2):179–81.PubMedPubMedCentral
22.
go back to reference Park K, Hong S, Chung W, Kim SS, Byeon SH, Seong GJ, Lee JB, Han SH. Inadvertent scleral perforation after strabismus surgery: incidence and association with refractive error. Can J Ophthalmol. 2008;43(6):669–72.CrossRefPubMed Park K, Hong S, Chung W, Kim SS, Byeon SH, Seong GJ, Lee JB, Han SH. Inadvertent scleral perforation after strabismus surgery: incidence and association with refractive error. Can J Ophthalmol. 2008;43(6):669–72.CrossRefPubMed
23.
go back to reference Schrader WF, Schargus M, Schneider E, Josifova T. Risks and sequelae of scleral perforation during peribulbar or retrobulbar anesthesia. J Cataract Refract Surg. 2010;36(6):885–9.CrossRefPubMed Schrader WF, Schargus M, Schneider E, Josifova T. Risks and sequelae of scleral perforation during peribulbar or retrobulbar anesthesia. J Cataract Refract Surg. 2010;36(6):885–9.CrossRefPubMed
Metadata
Title
Vitreous hemorrhage and Rhegmatogenous retinal detachment that developed after botulinum toxin injection to the extraocular muscle: case report
Authors
Dong Hyun Lee
Jinu Han
Sueng-Han Han
Sung Chul Lee
Min Kim
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2017
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-017-0649-2

Other articles of this Issue 1/2017

BMC Ophthalmology 1/2017 Go to the issue